Very interesting new research that shows that Inteferon beta 1b (available in Betaseron) might work by preventing leukocytes (white blood cells) from crossing the blood brain barrier.
"Adhesion molecules (AMs) are believed to regulate the transmigration of blood leukocytes across the blood-brain barrier (BBB), which is an essential step in the pathogenesis of multiple sclerosis (MS)...
The expression levels of cell surface bound AMs on blood MNC remained stable during treatment. Untreated MS patients, however, showed a continuous decrease in the expression of cell surface bound AM expression over 18 months. Stabilisation of the expression of cell surface bound AMs on blood MNC may indicate the beneficial effects of IFN-beta(1b) therapy in MS patients."
PMID: 15083294 [PubMed - in process]
Click "read more" for the full abstract...